Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1
OBR Daily - Our Oncology Focused E-News Service

Register for OBR daily

Warning: Missing argument 1 for showSidebarBanner(), called in /home2/don/public_html/sidebar_obrgreen.php on line 38 and defined in /home2/don/public_html/include/banners.php on line 243

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.20 0.0500 +33.33%
CNDO $2.41 0.3600 +17.56%
ONTY $1.86 0.1700 +10.06%
NLNK $38.47 3.1900 +9.04%
IDRA $3.00 0.2000 +7.14%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

IMNP $2.62 -0.1300 -4.73%
Kite $42.96 -1.2400 -2.81%
ARGS $8.50 -0.2200 -2.52%
MEIP $6.73 -0.1600 -2.32%
SRNE $3.80 -0.0900 -2.31%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Next > | Last >>

2014 Physician Payment Advocacy Highlights

(ASH) Nov 13, 2014 - Over the past year, ASH has continued to be very active on physician payment issues.
read article 

2014 ASH Advocacy Efforts to Ensure Access to Safe and Effective Hematologic Drugs

(ASH) Nov 13, 2014 - Over the past several years, shortages of drugs and biologics used to treat patients with hematologic diseases, including leukemia and lymphoma, have become critical and life-threatening.
read article 

The New Era of Medicaid and Hematology

(ASH) Nov 12, 2014 - On a national basis, Medicare is probably the most important payer for hematology.
read article 

Study Looks at Value Vs. Cost in Proton and X-Ray Therapy Delivery

(Proton Therapy Today) Nov 10, 2014 - A proof of concept study from the University of Texas MD Anderson Cancer Center shows that the episodic cost of care using intensity modulated proton therapy (IMPT) in advanced-stage head and neck cancer is less than that of intensity modulated radiation therapy (IMRT), also known as X-ray or photon therapy.
read article 

Cancer-Care Giant Is Investigated Over Medicare Billing

(Wall Street Journal) Nov 13, 2014 - The Justice Department is investigating whether a cancer-care giant improperly billed Medicare for a procedure when it administered radiation therapy to patients—the second time the company has faced federal scrutiny this year.
read article (paid subscription required) 

Bexxar For Lymphoma: Gone But Not Forgotten

(Medscape Medical News) Nov 13, 2014 - The radiolabeled monoclonal antibody was withdrawn from the market more than a year ago, but a few have not forgotten its value in advanced lymphoma, and there's hope for a comeback in generic form.
read article (free registration required) 

ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data at the Society for Neuro-Oncology Annual Meeting 2014

(San Francisco Business Times) Nov 14, 2014 – Continued positive trends in overall survival and progression-free survival; phase 3 registration program anticipated to start 1H15; company to host conference call on Tuesday, November 18th.
read article 

Secondhand Smoke in Vehicles Exposes Nonsmokers to Toxic Compounds

(AACR) Nov 14, 2014 - Secondhand smoke in the confined space of a motor vehicle resulted in exposure to several tobacco smoke toxins, and may ultimately increase risk for cancer and for respiratory and cardiovascular diseases in nonsmokers, according to a new study.
read press release 

New Study Links Wireless Phone Use and Malignant Brain Cancer

(New York Daily News) Nov 12, 2014 – The new evidence from Sweden contradicts the biggest study so far on the topic: The international Interphone study, funded in part by cell phone manufacturers, didn't find strong evidence that cell phones increased brain tumor risk.
read article 

UNC Researchers Silence Leading Cancer-Causing Gene

(UNC Health Care) Nov 13, 2014 - Researchers from the UNC School of Medicine and colleagues at The University of Texas MD Anderson Cancer Center have developed a new approach to block the KRAS oncogene, one of the most frequently mutated genes in human cancer.
read press release 

Scientists Uncover Vast Numbers of DNA ‘Blind Spots’ That May Hide Cancer-Causing Mistakes

(Cancer Research UK) Nov 14, 2014 - Cancer Research UK scientists have found more than 400 ‘blind spots’ in DNA which could hide cancer-causing gene faults, according to research published today in Cancer Research.
read press release 

New Hope For Bone Marrow Transplant Patients

(QIMR Berghofer MRI [Queensland, AU]) Nov 14, 2014 - Clinical trials led by QIMR Berghofer Medical Research Institute and the Royal Brisbane and Women’s Hospital are set to change international practice for the treatment of leukaemia patients undergoing bone marrow transplants.
read press release 

Thin Melanomas Cause Greater Number of Deaths

(Reuters Health) Nov 13, 2014 - More people are dying from melanomas thinner than a dime than from the thicker cancerous skin lesions long thought to be more dangerous, according to a new study from Queensland, Australia.
read article 

More Details on Possible Immunotherapy For Glioblastoma

(Medscape Medical News) Nov 14, 2014 - The mechanism of action of a promising experimental tumor-cell-derived vaccine for the treatment of glioblastomas has been revealed in a series of experiments conducted by American scientists.
read article (free registration required) 

High-Tech Goggles Help Surgeons Visualize Tumors

(Medscape Medical News) Nov 13, 2014 - Augmented reality, a Google Glass–like technology, could help surgeons prepare to resect tumors, report researchers here at the American College of Surgeons 2014 Clinical Congress.
read article (free registration required) 

Transplant Best For HIV Patients With Liver Cancer

(MedPage Today) Nov 13, 2014 - Liver transplant is the best treatment option for people with HIV and hepatocellular carcinoma, a researcher said here.
read article (free registration required) 

The Cancer Breakthrough With Big Implications

(TIME) Nov 13, 2014 - Once you’ve been diagnosed with cancer, you’re sent for a dizzying array of tests — but most of them are focused on you, as the living host of the tumors, and not on the malignant growths themselves.
read article 

In Its Bumpy Second Life, Geron Signs Top Drug Over to J&J

(Xconomy San Francisco) Nov 13, 2014 - As we saw this week with Dendreon, pioneers in the biomedical industry can end up with arrows in their back, bleeding to death. Geron has avoided that fate.
read article 

Puma Biotech Says Cancer Drug Fails Mid-Stage Study

(Reuters) Nov 13, 2014 - Puma Biotechnology Inc said its cancer drug failed as a primary treatment for breast cancer patients in a mid-stage study, sending its shares down 14 percent in extended trading.
read article 

Geron Could Get $935M in Blood Disorder Drug Deal

(BloombergBusinessweek/Associated Press) Nov 13, 2014 - Geron Corp. said Thursday it could get more than $900 million from a deal to develop its blood disorder drug imetelstat with a unit of Johnson & Johnson.
read article 

Cardinal Health Launches Online Tool To Help Retail Pharmacies Make It Easier For Patients to Compare Medicare Part D Plans

(Cardinal Health) Nov 13, 2014 - With the window for Medicare enrollment open from mid-October through Dec. 7, Cardinal Health recently launched a new online tool, developed by eHealth, Inc, that its retail pharmacy customers can use to help their patients compare Medicare Part D prescription drug plans.
read corporate press release 

AstraZeneca to Test Whether It Can Undo Effects of Its Own Heart Drug

(The Telegraph [UK]) Nov 13, 2014 - AstraZeneca is to run trials to determine whether it can reverse the effect of one of its drugs.
read article 

Valeant, Allergan Scuffle For Doctors

(Wall Street Journal) Nov 12, 2014 - As it fights to buy Botox maker Allergan Inc., Valeant Pharmaceuticals International Inc. is investing cash and time wooing the doctors it would need on its side after a takeover.
read article (paid subscription required) 

Growth of Digital Pharmaceutical Marketing Tactics Targeting Physicians Requires New Industry Standards, According to Penn Researchers

(Penn Medicine) Nov 12, 2014 - As pharmaceutical marketing activities in recent years have shifted away from traditional face-to-face methods towards more digital interactions, physicians may not be aware of the new ways they’re being marketed to, necessitating greater transparency and reporting.
read press release 

U.S. Prices Soaring For Some Generic Drugs, Experts Say

(U.S. News & World Report/HealthDay News) Nov 12, 2014 - Market forces are dramatically driving up the cost of some generic drugs, prompting U.S. investigations into the pricing of what should be cheap alternatives to brand-name medications.
read article